CAS: 56766-13-3; 4-(3-Oxobutanamido)Benzamide

该化合物是一种有机化合物,具有一种复杂的结构,其特点是有矿,甲醛和乙酰胺的功能组群,这种化合物一般在室温时是固体,在极地有机溶剂中可溶解.其分子结构包括一个配有氨酸衍生物的成型体(-CHO),有助于其再活和在有机合成中的潜在应用.这种无线协会的存在表明,它可能具有氢结合和与生物系统潜在互动等特性.这种化合物可能因其潜在的生物活动而对药物研究和开发具有兴趣,尽管其具体的生物特性需要进一步调查.此外,其合成和定性将涉及标准的有机化学技术,包括确认其结构的光谱学方法.

结构式图片

上下游产品

4-aminobenzamide ethyl acetoacetate .I. pigment yellow 12C.I. pigment yellow 12

合成工艺路线路线简述

    📜对氨基苯甲酰胺,乙酰乙酸乙酯置于potassium Tert-Butylate体系中,化学反应 2.0H,反应生成 4-甲酰氨基-N-乙酰乙酰苯胺
    参考文献:Discovery And Optimization Of Novel,Selective Histone Methyltransferase Set7 Inhibitors By Pharmacophore-And Docking-Based Virtual Screening
    标题:Discovery And Optimization Of Novel,Selective Histone Methyltransferase Set7 Inhibitors By Pharmacophore-And Docking-Based Virtual Screening
    摘要:Histone Methyltransferases Are Involved In Various Biological Functions,And These Methylation Regulating Enzymes' Abnormal Expression Or Activity Has Been Noted In Several Human Cancers. Within This Context,Set Domain-Containing (Lysine Methyltransferase) 7 (Set7,Also Called Kmt7,Setd7,Set9) Is Of Increasing Significance Due To Its Diverse Roles In Biological Functions And Diseases,Such As Diabetes,Cancers,Alopecia Areata,Atherosclerotic Vascular Disease,Hiv,And Hcv. In This Study,Dc-S100,Which Was Discovered By Pharmacophore-And Docking-Based Virtual Screening,Was Identified As The Hit Compound Of Set7 Inhibitor. Structure-Activity Relationship (Sar) Analysis Was Performed On Analogs Of Dc-S100 And According To The Putative Binding Mode Of Dc-S100,Structure Modifications Were Made To Improve Its Activity. Of Note,Compounds Dc-S238 And Dc-S239,With Ic50 Values Of 4.88 And 4.59 Mu M,Respectively,Displayed Selectivity For Dnmt1,Dot1L,Ezh2,Nsd1,Setd8,And G9A. Taken Together,Dc-S238 And Dc-S239 Can Serve As Leads For Further Investigation As Set7 Inhibitors And The Chemical Toolkits For Functional Biology Studies Of Set7.
    DOI:10.1021/acs.Jmedchem.5B01154

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.bbrc.2023.08.050
    摘要:Ikeda Y, Davis MI, Sumita K, Zheng Y, Kofuji S, Sasaki M, Hirota Y, Pragani R, Shen M, Boxer MB, Takeuchi K, Senda T, Simeonov A, Sasaki AT. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and Biophysical Research Communications. 2023 Oct;679():116–21. doi: 10.1016/j.bbrc.2023.08.050.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知